Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

UPS Boosts Dividend; Announces New $10 Bln Stock Buyback Authorization

RELATED NEWS
Trade UPS now with 

United Parcel Service, Inc. (UPS: Quote) said Thursday that its Board of Directors has declared a regular quarterly dividend of $0.62 per share on all outstanding Class A and Class B shares, an increase of 8.8%.

The dividend is payable on Mar. 12 to shareholders of record on February 25.

"This dividend increase reflects the power of the UPS business model to deliver consistent returns to shareowners," said Scott Davis, UPS Chairman and CEO. "During 2012 we generated almost $5.4 billion in free cash flow, enabling reinvestment for growth and greater shareowner distributions, which are a top priority at UPS."

The company also said its board has reauthorized the company's share repurchase program for $10 billion.

The new share repurchase authorization has no expiration date and replaces the one approved in 2012. On January 31, UPS announced an increase in its 2013 share repurchase plans from $1.5 billion to $4.0 billion.

UPS also said its board has been advised by John Thompson, CEO of Virtual Instruments Corporation and the former Chairman and CEO of Symantec, that he will not stand for re-election when his term expires in May. Thompson has served on the UPS board since 2000, making him the second longest serving board member.

Register
To receive FREE breaking news email alerts for United Parcel Service and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Micro-blogging site Twitter Inc said Tuesday after the markets closed that its second quarter loss widened from last year, hurt mainly by stock-based compensation expense, even as revenue more than doubled thanks to growth in advertising. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Pharmaceutical giant Pfizer, Inc., which was aspiring to buy British drug maker AstraZeneca Plc, reported Tuesday a profit for the second quarter that plunged 79 percent from last year, which reflected hefty gains from animal health business sales. Total revenues declined 2 percent, as it continued to be hurt by generic competition for major drugs. Home improvement and building products company Masco Corp. said Monday after the markets closed that its second quarter profit jumped 78% from last year, as revenue increased and margins improved amid strong performance of its Plumbing Products, Installation and Other Services and Decorative Architectural Products segments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.